A new weight-loss shot is being hailed as a “game changer” — with the potential to cut diabetes risk by 50% and “fight obesity as a disease” for the first time, according to a new study.
The research, conducted by the University of Alabama, found that weekly jabs of the drug semaglutide in overweight and obese research participants caused an average weight loss of 37 pounds.
“We have not seen this degree of weight loss with any previous medication,” said lead study author Dr. Timothy Garvey in a statement. “More than 50% of trial participants are losing 15% of their body weight, and anywhere between a third and 40% of participants are losing 20% of their body weight.”
Read more at https://nypost.com/2022/09/12/weekly-weight-loss-shot-a-game-changer-in-obesity-medicine/
#weightloss #semaglutide #obesity
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Subscribe to New York Post Sports: https://www.youtube.com/c/nypostsports
Catch the latest news here: https://nypost.com/
Follow The New York Post on:
Twitter – https://twitter.com/nypost
Facebook – https://www.facebook.com/NYPost